Marker Therapeutics Inc (MRKR)

[rfj1862]

Both parties want this data out as soon as possible but obviously it doesn’t make sense to prematurely jump the gun and issue a PR with it when it would be in everyone’s best interest to present at AACR or ESMO.

Speaking as someone who had all 6 of his abstracts accepted to ASCO....

I really don't think it is "in everyone's best interest to present at AACR or ESMO" from a business perspective. Abstract acceptance is almost meaningless, it's not a real peer review--people scan the abstracts in like 30 seconds and put them in the yes or no pile. So an abstract being accepted to any meeting isn't really a meaningful seal of approval.

All biotechs should be PRing their data as soon as it is available instead of waiting for artificial embargoes to be lifted. The only people the embargoes benefit are those who get information from the slow leaks that inevitably occur in the months between submission and the meeting, and you know damn well that these companies are leaking all over the place.